CervoMed Inc.
CRVO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $56,299 | $79,632 | $20,365 |
| - Cash | $9,437 | $8,321 | $10,502 | $8,999 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $47,978 | $69,131 | $11,366 |
| Revenue | $323 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $323 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$7,727 | -$6,616 | -$5,303 | -$7,241 |
| % Margin | -2,395.3% | – | – | – |
| Net Income | -$7,727 | -$6,258 | -$4,894 | -$6,706 |
| % Margin | -2,395.3% | – | – | – |
| EPS Diluted | -0.84 | -0.7 | -0.56 | -0.77 |
| % Growth | -20% | -25% | 27.3% | – |
| Operating Cash Flow | -$6,465 | -$6,515 | -$3,894 | -$8,051 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$6,465 | -$6,515 | -$3,894 | -$8,051 |